AI assistant
PFIZER INC — Director's Dealing 2010
Feb 1, 2010
29831_dirs_2010-02-01_c1f6f361-9931-4b54-be0d-a69b4a395068.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2009-12-31
Reporting Person: CANGIALOSI LORETTA V (Sr. Vice President, Controller)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2009-12-31 | Common Stock | A | 8246 | — | Acquired | 181057 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2009-12-31 | Stock Appreciation Rights | $18.19 | A | 32120 | Acquired | 2014-12-31 | Common Stock (32120) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2266 | Indirect |
Footnotes
F1: The reported transaction constitutes the grant of restricted stock units, which will vest and be settled in shares of Pfizer common stock on the third anniversary of the date of grant, provided that the reporting person remains in the continuous employ of Pfizer until that anniversary date.
F2: The stock appreciation rights will vest on the third anniversary of the date of grant, provided that the reporting person remains in the continuous employ of Pfizer until that anniversary date, and will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.